Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
The article linked and excerpted below is, to date, the most complete synopsis I have read on the issue of Antineoplaston Therapy (ANP) and Stanislaw Burzynski M.D. (BRI) so I thought I would combine it with my own ANP experiences and use it for a blog post for multiple myeloma patients/survivors/caregivers to learn about ANP and MM.
The first thing I must stress is that ANP and the BRI are controversial. It is difficult if not impossible to get a fair assessment of the therapy- from anyone who is educated about the issues. While several medical professionals have gone on record as supporting both Burzynski and ANP therapy, I have never spoken to a board certified oncologist who holds anything but contempt for the BRI and ANP. When I mention my own MM experience from diagnosis through remission, its as if the oncologist didn’t hear me…
It is for this reason that the first thing this blog post will do is list those therapies that I think most everyone will agree have anti-mm action. Meaning, do the therapies listed below before you undergo ANP.
The therapies above are the basics for NDMM patients. Now, let me speak directly to ANP and the article linked below.
I’ve always found it to be ironic that both my ASCT at the time (12/95) and ANP were considered to be “experimental therapies” yet my health insurance paid for my ASCT yet denied my ANP for being experimental…
If I knew then what I know now-
The bottom line is that anyone who is diagnosed with an incurable blood cancer like MM must learn all they can about any therapy that may help them achieve their goals.
“Antineoplaston therapy is an experimental cancer treatment. It was developed in the 1970s by Dr. Stanislaw Burzynski….Continue reading to learn more about antineoplaston therapy, the theory behind it, and why you should be cautious…
Antineoplastons are naturally occurring chemical compounds. They’re found in blood and urine. These compounds are made up of amino acids and peptides.
Burzynski used antineoplastons separated from human blood and urine as he was developing his treatment. Since the 1980s, antineoplastons have been manufactured from chemicals…
…Burzynski believes antineoplastons are part of our natural defense system and that they help prevent abnormal cell growth. He suggests that some people don’t have enough of them, which allows cancer to develop and grow unchecked.
By adding more antineoplastons, the theory is that those substances may:
Antineoplastons can be taken orally or injected into the bloodstream…
There haven’t been enough clinical trials to understand the full range and severity of possible side effects. In trials that have been conducted to date, side effects may include…
There have been studies that indicate a positive response to treatment. However, these studies have been conducted at Burzynski’s own clinic, so they’re biased…
Clinical trials generally go on for a few years. Burzynski’s trials have continued for decades…
When looking at any alternative or experimental treatments for cancer, take a good hard look at the evidence…
When evaluating the research, look for studies that:
Due to lack of evidence, this therapy isn’t approved by the FDA to treat cancer or any other condition.
Burzynski’s clinic in Texas does have permission to run clinical trials. He has been the subject of several investigations and legal proceedings…
Antineoplaston therapy costs thousands of dollars per month. Health insurers may consider the therapy investigational and medically unnecessary, so it may not be covered under your insurance.
You may come across a variety of websites promoting this therapy, but it’s still an unproven treatment. No peer-reviewed research has been published. No major scientific organizations support the treatment.
Decisions about alternative cancer treatments are yours to make. But if you’re considering antineoplaston therapy for cancer, take time to discuss it with your oncologist”
PERSONALIZED TREATMENT AT BURZYNSKI CLINIC
Comparison of Responses in 20 selected most common cancers (as of September 21, 2015)
|Diagnosis||No. of patients||OR (%)||SD (%)||PD (%)|
|Carcinoma of unknown primary||42||57||36||7|
|Head and Neck Cancer||87||51||29||20|
|Urinary Bladder and Urothelial Cancer||39||45||32||23|
|Esophageal and Stomach Cancer||55||44||29||27|
|Uterine, Cervix, Vulvar, Endometrium||51||39||31||30|
|Biliary Tract Tumor||20||30||40||30|
Data based on medical records of 2,280 evaluable patients
OR: Objective Response – includes CR and PR.
CR: Complete Response. Complete disappearance of all signs of cancer in response to treatment of 4 weeks or longer.
PR: Partial Response. More than 50% decrease in the size of the tumors in response to treatment of 4 weeks or longer.
SD: Stable Disease. No decrease or increase in the size of the tumors, but no progression, in response to treatment of 12 weeks or longer.
PD: Progressive Disease. More then 50% increase in size of the tumors (the sum of cross-sectional area of the tumors), in response to treatment of 4 weeks or longer.
Evaluable Patients. Patients who remained on treatment long enough to enable an objective evaluation of the response.